President & CEO of Integra LifeSciences Holdings Corp. (IART, Financial) Stuart Essig sells 21,005 shares of IART on 12/07/2009 at an average price of $33.4 a share.
Integra LifeSciences Corp. develops, manufactures and markets medical devices, implants and biomaterials primarily used in the treatment of burns and skin defects, spinal and cranial disorders, orthopedics and other surgical applications. Integra seeks to be the world's leading company specializing in implantable medical and biopharmaceutical therapies to target and control cell behavior, and to build shareholder value by acquiring, discovering, and developing cost-effective, off-the-shelf products that satisfy unmet medical needs. Integra Lifesciences Holdings Corp. has a market cap of $968.1 million; its shares were traded at around $33.99 with a P/E ratio of 16.7 and P/S ratio of 1.5. Integra Lifesciences Holdings Corp. had an annual average earning growth of 24.5% over the past 5 years.
IART is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Integra LifeSciences Corp. develops, manufactures and markets medical devices, implants and biomaterials primarily used in the treatment of burns and skin defects, spinal and cranial disorders, orthopedics and other surgical applications. Integra seeks to be the world's leading company specializing in implantable medical and biopharmaceutical therapies to target and control cell behavior, and to build shareholder value by acquiring, discovering, and developing cost-effective, off-the-shelf products that satisfy unmet medical needs. Integra Lifesciences Holdings Corp. has a market cap of $968.1 million; its shares were traded at around $33.99 with a P/E ratio of 16.7 and P/S ratio of 1.5. Integra Lifesciences Holdings Corp. had an annual average earning growth of 24.5% over the past 5 years.
IART is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Insiders' Positions with IART
- Sell:: EVP, Finance & Admin & CFO John B Iii Henneman sold 25,000 shares of IART stock on 11/17/2009 at the average price of 32.3, the price of the stock has increased by 5.23% since
- Sell:: EVP, Finance & Admin & CFO John B Iii Henneman sold 5,500 shares of IART stock on 08/26/2009 at the average price of 34.83, the price of the stock has decreased by 2.41% since
Insiders' Positions with IART
- Sell:: Sr.VP Regulatory, Quality Assr Judith Ogrady sold 3,000 shares of IART stock on 12/04/2009 at the average price of 33.08, the price of the stock has increased by 2.75% since
- Sell:: Director Keith Bradley sold 1,853 shares of IART stock on 11/24/2009 at the average price of 32.59, the price of the stock has increased by 4.3% since
- Sell:: Executive Vice President & COO Gerard S Carlozzi sold 28,085 shares of IART stock on 09/21/2009 at the average price of 35.78, the price of the stock has decreased by 5% since
